4//SEC Filing
LaFrance Norman D. 4
Accession 0001209191-09-029560
CIK 0001340752other
Filed
May 28, 8:00 PM ET
Accepted
May 29, 4:19 PM ET
Size
9.8 KB
Accession
0001209191-09-029560
Insider Transaction Report
Form 4
LaFrance Norman D.
Sr. VP Clinical Dev and CMO
Transactions
- Sale
Common Stock
2009-05-28$3.76/sh−6,093$22,910→ 16,657 total
Footnotes (1)
- [F1]Shares were sold through broker to cover withholding tax liabilities on the vesting of shares of restricted stock.
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeother
Related Parties
1- filerCIK 0001397768
Filing Metadata
- Form type
- 4
- Filed
- May 28, 8:00 PM ET
- Accepted
- May 29, 4:19 PM ET
- Size
- 9.8 KB